References
- Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008;103:1541–9.
- van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82–90.
- Rockey DC. Occult gastrointestinal bleeding. N Engl J Med 1999;341:38–46.
- Meguro T. [Measurement of fecal hemoglobin-haptoglobin complex as a new diagnostic tool of lower gastrointestinal tract diseases]. Hokkaido Igaku Zasshi 1994;69:995–1009.
- Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42:1589–600.
- Chalkias A, Nikotian G, Koutsovasilis A, Bramis J, Manouras A, Mystrioti D, et al. Patients with colorectal cancer are characterized by increased concentration of fecal hb-Hpt complex, myeloperoxidase, and secretory IgA. Am J Clin Oncol 2011;34:561–6.
- Haug U, Hundt S, Brenner H. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol 2010;105:682–90.
- Karl J, Wild N, Tacke M, Andres H, Garczarek U, Rollinger W, et al. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers. Clin Gastroenterol Hepatol 2008;6:1122–8.
- Sieg A, Thoms C, Luthgens K, John MR, Schmidt-Gayk H. Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces. Int J Colorectal Dis 1999;14:267–71.
- Chiba H, Sekiguchi M, Ito T, Tsuji Y, Ohata K, Ohno A, et al. Is it worthwhile to perform capsule endoscopy for asymptomatic patients with positive immunochemical faecal occult blood test? Dig Dis Sci 2011;56:3459–62.